Soleno Therapeutics Receives Strong Buy Rating with Target Price of $119.60

Summary

Soleno Therapeutics has received a strong buy rating with a price target of $119.60, implying an 85.28% upside from current levels. LifeSci Capital also maintained a buy rating with a $120.00 price target.Tip Ranks

Impact Analysis

So basically, Soleno Therapeutics is getting a lot of love from analysts right now. The strong buy rating and the price target of $119.60, which implies an 85.28% upside, are significant. LifeSci Capital’s similar target of $120.00 reinforces this bullish sentiment.Tip Ranks The interesting part isn’t just the ratings but the timing—this comes after a recent 8.5% price increase and strong performance metrics over the past months.AnueSec This suggests that analysts see sustained momentum and potential for further growth. However, it’s worth noting that the stock has already seen substantial gains, so the risk of a pullback exists if expectations aren’t met. Market’s missing that the current price already reflects a lot of optimism. I’d read this as a signal to watch for execution on upcoming milestones to justify these high targets. Feels like they’re setting the stage for a big move, but the execution risk is high.